MicroVention | Terumo™

Terumo Website
  • Home

    • Aneurysm Therapy
    • Ischemic Stroke and Carotid Artery Disease
    • Neurovascular Malformations
    • Access Product Solutions
  • Products

    • About Us
    • Executive Team
    • News
    • Events
    • Compliance
    • Overview
    • Job Openings
  • Contact

  • Clinical Education
  • Glossary
  • MV Associates
  • Terumo Group
  • Press Resources
  • Aneurysm Therapy

    Aneurysm Therapy

  • Ischemic Stroke and Carotid Artery Disease

    Ischemic Stroke and Carotid Artery Disease

  • Neurovascular Malformation

    Neurovascular Malformations

  • Access Product Solutions

    Access Product Solutions

  • Home

News & Press

Sep 29, 2022

MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient Lives

MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corporation, celebrates its 25-year anniversary on September 29, 2022. Founded in 1997 by a handful of Associates in a small facility in Southern California, MicroVention is now a worldwide community with over 3,000 Associates and distributors worldwide, operating in over 70 countries with offices across the United States, Europe, Asia, and Costa Rica.

All Types
All Types Articles HR Press Releases
2019
All Years 2010 2012 2013 2015 2016 2017 2018 2019 2020 2021 2022

Oct 18, 2019

Treating brain aneurysms before they rupture: How Indiana doctors are using a new aneurysm treatment

The Woven EndoBridge (WEB) Aneurysm Embolization System, approved for use in January, has made its way to Indiana.

Apr 24, 2019

MicroVention Announces Positive Safety and Effectiveness Results in WEB-IT Pivotal Trial Published in Journal of Neurointerventional Surgery

The WEB-IT pivotal trial highlights positive clinical outcomes with the WEB® Aneurysm Embolization System, the only intrasaccular flow disruptor approved in the United States.

Jan 07, 2019

Novel Intrasaccular Aneurysm Treatment Device Receives FDA PMA Approval

The WEB® Aneurysm Embolization System is the first intrasaccular flow disruptor PMA approved for the embolization of wide neck bifurcation aneurysms

    • Aneurysm Therapy
    • Ischemic Stroke and Carotid Artery Disease
    • Neurovascular Malformations
    • Access Product Solutions
  • Products

    • About Us
    • Executive Team
    • News
    • Events
    • Compliance
    • Overview
    • Job Openings
  • Contact

  • Clinical Education
  • Glossary
  • MV Associates
  • Terumo Group
  • Press Resources
Europe, Middle East & Africa

©2023 MicroVention Inc.

Privacy Statement

For Suppliers

Terms of Use

Ordering Info Terms & Conditions

Made inHAUSHAUS is a creative design agency based in Los Angeles, California